A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)
NCT00002170 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
The purpose of this study is to see if it is safe and effective to give Viracept to AIDS patients who are being treated for MAC.
Conditions
- Mycobacterium Avium-Intracellulare Infection
- HIV Infections
Interventions
- DRUG
-
Nelfinavir mesylate
Sponsors & Collaborators
-
Agouron Pharmaceuticals
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 13 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy
NCT00002089 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS
NCT00001058 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Azithromycin in the Prevention of Mycobacterium Avium Complex Disease (MAC) in HIV-Infected Patients
NCT00002309 ·Status: COMPLETED ·Phase: NA
-
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
NCT00002032 ·Status: COMPLETED ·Phase: NA
-
A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive Patients
NCT00000907 ·Status: COMPLETED
-
Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS
NCT00001047 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS
NCT00000644 ·Status: COMPLETED ·Phase: PHASE2
-
A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS
NCT00001995 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients
NCT00000947 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients
NCT00002336 ·Status: COMPLETED ·Phase: NA
-
Viracept Expanded Access Program
NCT00002165 ·Status: COMPLETED ·Phase: NA
-
A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo
NCT00002101 ·Status: COMPLETED ·Phase: PHASE3
-
Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV
NCT00002104 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Lobucavir in Patients With AIDS
NCT00002352 ·Status: COMPLETED ·Phase: NA
-
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study
NCT00002080 ·Status: COMPLETED ·Phase: NA
-
A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease
NCT00002058 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients
NCT00001030 ·Status: COMPLETED ·Phase: PHASE3
-
Multicenter AIDS Cohort Study (MACS)
NCT00046280 ·Status: UNKNOWN
-
Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.
NCT00002192 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of AIDS and AIDS Related Complex. Part-1- Treatment of Patients With ARC (AZT Vs. Placebo)
NCT00002063 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Patients Who Have Not Had Success With Zidovudine
NCT00001025 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection.
NCT00002097 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89
NCT00002141 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study of Methotrexate for HIV Infection
NCT00000834 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients
NCT00002122 ·Status: COMPLETED ·Phase: PHASE3